← Back to Screener
Neogen Corp (NEOG)
Price$8.90
Value ScoreC
Growth ScoreC
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)40.90%
Price vs S&P 500 (4W)-1.65%
VGM Score52.54
Market Capitalization$1.94B
All Metrics
P/CF (Annual)33.26x
Book Value / Share (Quarterly)$9.66
P/TBV (Annual)1.87x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)19.28%
Cash Flow / Share (Quarterly)$0.03
Price vs S&P 500 (YTD)19.17%
Gross Margin (TTM)45.20%
Net Profit Margin (TTM)-69.93%
EPS (TTM)$-2.80
10-Day Avg Trading Volume3.06M
EPS Excl Extra (TTM)$-2.80
Revenue Growth (5Y)16.43%
EPS (Annual)$-5.03
ROI (Annual)-36.83%
Gross Margin (Annual)47.10%
Net Profit Margin (5Y Avg)-20.74%
Cash / Share (Quarterly)$0.73
Revenue Growth QoQ (YoY)-4.43%
ROA (Last FY)-31.71%
Revenue Growth TTM (YoY)-3.91%
EBITD / Share (TTM)$-2.12
ROE (5Y Avg)-8.21%
Operating Margin (TTM)-64.28%
Cash Flow / Share (Annual)$-0.21
P/B Ratio0.92x
P/B Ratio (Quarterly)1.15x
Net Income / Employee (Annual)$-367,200
EV / Revenue (TTM)2.95x
Net Interest Coverage (TTM)-14.69x
ROA (TTM)-17.98%
EV / EBITDA (TTM)16.76x
EPS Incl Extra (Annual)$-5.03
Current Ratio (Annual)3.32x
Quick Ratio (Quarterly)2.42x
3-Month Avg Trading Volume2.75M
52-Week Price Return81.26%
Revenue / Employee (TTM)$292,700
Tangible BV / Share (Quarterly)$3.49
P/S Ratio (Annual)2.17x
Asset Turnover (Annual)0.26x
52-Week High$11.43
Operating Margin (5Y Avg)-16.14%
EPS Excl Extra (Annual)$-5.03
CapEx CAGR (5Y)34.18%
Tangible BV CAGR (5Y)0.07%
26-Week Price Return48.83%
Quick Ratio (Annual)1.91x
13-Week Price Return-16.74%
Total Debt / Equity (Annual)0.43x
Current Ratio (Quarterly)3.92x
Enterprise Value$2.57B
Revenue / Share Growth (5Y)0.84%
Asset Turnover (TTM)0.26x
Book Value / Share Growth (5Y)6.90%
Revenue / Employee (Annual)$300,800
Inventory Turnover (Annual)2.49x
Pretax Margin (Annual)-126.65%
Cash / Share (Annual)$0.60
3-Month Return Std Dev49.07%
Gross Margin (5Y Avg)47.73%
Net Income / Employee (TTM)$-204,700
EBITDA Interim CAGR (5Y)-1.83%
ROE (Last FY)-52.72%
Net Interest Coverage (Annual)-8.83x
EPS Basic Excl Extra (Annual)$-5.03
P/FCF (TTM)100.61x
Receivables Turnover (TTM)5.86x
EV / Free Cash Flow (TTM)421.01x
Total Debt / Equity (Quarterly)0.38x
EPS Incl Extra (TTM)$-2.80
Receivables Turnover (Annual)5.48x
ROI (TTM)-20.87%
P/S Ratio (TTM)2.23x
Pretax Margin (5Y Avg)-20.68%
Revenue / Share (Annual)$4.12
Tangible BV / Share (Annual)$3.05
Forward P/E30.87x
Price vs S&P 500 (52W)56.90%
Year-to-Date Return27.32%
5-Day Price Return-0.22%
EPS Normalized (Annual)$-5.03
ROA (5Y Avg)-4.19%
Net Profit Margin (Annual)-122.06%
Month-to-Date Return-0.78%
Cash Flow / Share (TTM)$0.39
EBITD / Share (Annual)$-4.34
Operating Margin (Annual)-118.59%
LT Debt / Equity (Annual)0.42x
P/CF (TTM)27.86x
ROI (5Y Avg)-4.99%
LT Debt / Equity (Quarterly)0.38x
EPS Basic Excl Extra (TTM)$-2.80
P/TBV (Quarterly)3.19x
P/B Ratio (Annual)0.60x
Inventory Turnover (TTM)2.60x
Pretax Margin (TTM)-72.15%
Book Value / Share (Annual)$9.56
Price vs S&P 500 (13W)-25.00%
Beta1.80x
P/FCF (Annual)44.42x
Revenue / Share (TTM)$4.00
ROE (TTM)-29.00%
52-Week Low$4.56
vGradeC
gGradeC
mGradeB
vgmGradeC
Show chart for
Earnings Surprise History
Q3 260.09est. 0.06
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.91
3.91
3.91
4.00
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NEOGNeogen Corp | C | C | B | $8.90 |
| IDXXIdexx Laboratories Inc | D | B | C | $562.16 |
| LNTHLantheus Holdings, Inc | C | B | B | $100.98 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | B | B | $22.99 |
| CLDXCelldex Therapeutics, Inc | F | F | C | $28.62 |
| NTLAIntellia Therapeutics, Inc | D | C | B | $13.54 |
| QDELQuidelOrtho Corporation Common Stock | C | C | D | $14.33 |
| ACHVAchieve Life Sciences, Inc. | F | F | B | $5.13 |
| MYGNMyriad Genetics Inc | C | C | C | $4.57 |
| TKNOAlpha Teknova, Inc. Common Stock | C | C | B | $4.56 |
| IMDXInsight Molecular Diagnostics Inc. Common Stock | F | D | C | $5.24 |
About
Neogen Corporation develops food and animal safety solutions, offering diagnostics to detect pathogens, toxins, allergens, and contaminants in food and animal feed. The company operates through two segments: food safety diagnostics and animal health products, which include veterinary pharmaceuticals, vaccines, instruments, and genomics testing services. Based in Lansing, Michigan, Neogen serves food processors and agricultural businesses seeking to ensure product safety and traceability.